YungShin Global Holding Corporation (TPE:3705)
Taiwan · Delayed Price · Currency is TWD 55.90
-0.20 (-0.36%)
Aug 29, 2025, 2:36 PM CST
YungShin Global Holding Market Cap
YungShin Global Holding has a market cap or net worth of 14.89 billion as of August 29, 2025. Its market cap has increased by 11.13% in one year.
Market Cap
14.89B
Enterprise Value
14.13B
Revenue
8.56B
Ranking
n/a
PE Ratio
15.11
Stock Price
55.90
Market Cap Chart
Since January 4, 2011, YungShin Global Holding's market cap has increased from 10.25B to 14.89B, an increase of 45.28%. That is a compound annual growth rate of 2.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 14.89B | 3.71% |
| Dec 31, 2024 | 14.36B | 15.91% |
| Dec 29, 2023 | 12.39B | 1.09% |
| Dec 30, 2022 | 12.25B | 7.10% |
| Dec 30, 2021 | 11.44B | -3.92% |
| Dec 31, 2020 | 11.91B | 4.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 295.47B |
| PharmaEssentia | 167.30B |
| Bora Pharmaceuticals Co., LTD. | 90.97B |
| Lotus Pharmaceutical | 50.89B |
| Oneness Biotech | 36.16B |
| Lumosa Therapeutics | 31.76B |
| Polaris Group | 31.13B |
| Center Laboratories | 26.64B |